Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Interaction of Chlormadinone Acetate with the Ouabain Binding Site of Na+, K+-ATPase

MARTIN WEHLING, ARNOLD SCHWARTZ, KYRA WHITMER, GUNTER GRUPP, INGRID L. GRUPP and EARL T. WALLICK
Molecular Pharmacology November 1981, 20 (3) 551-557;
MARTIN WEHLING
Departments of Pharmacology and Cell Biophysics, Medicine, and Physiology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ARNOLD SCHWARTZ
Departments of Pharmacology and Cell Biophysics, Medicine, and Physiology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KYRA WHITMER
Departments of Pharmacology and Cell Biophysics, Medicine, and Physiology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GUNTER GRUPP
Departments of Pharmacology and Cell Biophysics, Medicine, and Physiology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
INGRID L. GRUPP
Departments of Pharmacology and Cell Biophysics, Medicine, and Physiology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EARL T. WALLICK
Departments of Pharmacology and Cell Biophysics, Medicine, and Physiology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Chlormadinone acetate, a hydroxyprogesterone derivative, reversibly inhibits both Na+,K+-ATPase activity and [3H]ouabain binding to the enzyme. Chlormadinone acetate substitutes for ouabain in "chasing" the label from the enzyme-[3H]ouabain complex. Chlormadinone acetate is a noncompetitive inhibitor of Na+,K+-ATPase with respect to ATP and is a competitive inhibitor with respect to potassium. The monovalent cation site which regulates ouabain binding to Na+,K+-ATPase (apparent KD for potassium = 1.4 mM) also regulates chlormadinone binding to Na+,K+-ATPase (apparent KD = 0.96 mM). The I50 values for chlormadinone acetate inhibition of Na+,K+-ATPase isolated from sheep kidney, cat heart, and guinea pig heart were 3,6, and 30 µM, respectively. Similar differences in species sensitivity have been found for ouabain and ouabagenin. These data suggest that chlormadinone acetate binds to the ouabain binding site of isolated Na+,K+-ATPase. Concentrations of chlormadinone acetate up to 30 µM can be obtained in unstirred solutions in glass vessels. However, the highest concentrations that could be obtained in muscle baths containing isolated strips of guinea pig left atria, or strips of cat atria and ventricle, aerated with 95% O2-5% CO2 were only 0.5-4 µM, and these concentrations did not prevent ouabain from binding to its receptor in intact muscles. Thus, it appears that chlormadinone acetate is not capable of modifying the pharmacological action of ouabain or of producing an inotropic action independently under these experimental conditions because of its limited solubility.

ACKNOWLEDGMENTS We extend our sincere appreciation to Drs. Frank S. LaBella and Ivan Bihler of the University of Manitoba for supplying chlormadinone acetate and for their review and critique of the manuscript. We should also like to thank Ms. Pam Smith for typing and editing.

  • Copyright © 1981 by The American Society for Pharmacology and Experimental Therapeutics

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 20, Issue 3
1 Nov 1981
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Interaction of Chlormadinone Acetate with the Ouabain Binding Site of Na+, K+-ATPase
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Interaction of Chlormadinone Acetate with the Ouabain Binding Site of Na+, K+-ATPase

MARTIN WEHLING, ARNOLD SCHWARTZ, KYRA WHITMER, GUNTER GRUPP, INGRID L. GRUPP and EARL T. WALLICK
Molecular Pharmacology November 1, 1981, 20 (3) 551-557;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Interaction of Chlormadinone Acetate with the Ouabain Binding Site of Na+, K+-ATPase

MARTIN WEHLING, ARNOLD SCHWARTZ, KYRA WHITMER, GUNTER GRUPP, INGRID L. GRUPP and EARL T. WALLICK
Molecular Pharmacology November 1, 1981, 20 (3) 551-557;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The binding site for KCI807 in the androgen receptor
  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics